Literature DB >> 8063616

Analysis of T cell receptor variability in fresh tumor-infiltrating lymphocytes from human head and neck cancer.

K Chikamatsu1, M Eura, K Nakano, Y Kanzaki, H Matsuoka, K Masuyama, T Ishikawa.   

Abstract

In this study, we analyzed T cell receptor (TCR) gene rearrangements in tumor-infiltrating lymphocytes (TIL) freshly obtained from 15 patients with head and neck cancer using the reversely transcribed polymerase chain reaction (RT-PCR) method. These TILs showed preferential expression of V alpha 10, V alpha 8 and V alpha 1, detected in 13 (87%), 11 (73%), and 9 cases (60%), respectively. The TCRV beta gene revealed diversity without preferential usage. The head and neck region is exposed to bacteria and viruses, so it is possible that the tumor site can become infected and accumulate T cells involved in infection and inflammation. Therefore, we also investigated TCR gene usage in T cells infiltrating in chronic sinusitis mucosa to address the question of whether the V alpha 1, V alpha 8, and V alpha 10 subfamilies are characteristic in TIL from squamous cell carcinoma of head and neck. TCR V alpha 10 gene usage was also the most common in V alpha segment in T cells infiltrating the sinus mucosa, but V alpha 1 and V alpha 8 were not detected in the T cells in sinusitis. These results indicate that the V alpha 10 subfamily, the preferred T cell population in both TIL and T cells in inflammatory disease, might be involved mainly in inflammation or infection. On the other hand, V alpha 1 and V alpha 8 appear to be relatively specific populations for antitumor immunity in head and neck cancer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8063616      PMCID: PMC5919524          DOI: 10.1111/j.1349-7006.1994.tb02405.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


tumor‐infiltrating lymphocytes T cell receptor complementary DNA reversely transcribed polymerase chain reaction major histocompatibility complex sodium dodecyl sulfate
  20 in total

1.  Selective usage of TCR V beta in tumor-specific CTL lines isolated from ovarian tumor-associated lymphocytes.

Authors:  C G Ioannides; R S Freedman
Journal:  Anticancer Res       Date:  1991 Sep-Oct       Impact factor: 2.480

2.  T cell receptor gene rearrangements of T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis (PBC): oligoclonality of PBC-derived T cell clones.

Authors:  U Moebius; M Manns; G Hess; G Kober; K H Meyer zum Büschenfelde; S C Meuer
Journal:  Eur J Immunol       Date:  1990-04       Impact factor: 5.532

3.  T-cell receptor variable region gene expression in cutaneous T-cell lymphomas.

Authors:  C B Gilks; V C Ho; R D Gascoyne; D J Ellison
Journal:  J Cutan Pathol       Date:  1992-02       Impact factor: 1.587

4.  Predominant expression of T cell receptor V alpha 7 in tumor-infiltrating lymphocytes of uveal melanoma.

Authors:  T Nitta; J R Oksenberg; N A Rao; L Steinman
Journal:  Science       Date:  1990-08-10       Impact factor: 47.728

5.  Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors.

Authors:  Y Shimizu; S Iwatsuki; R B Herberman; T L Whiteside
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

6.  Analysis of T-cell receptor V region gene usage of cytotoxic T-lymphocytes and tumor-infiltrating lymphocytes derived from human autologous gastric signet ring cell carcinomas.

Authors:  H Ikeda; N Sato; A Matsuura; K Kikuchi
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

7.  Restricted T cell receptor V-beta and J-beta usage in T cells from interleukin-2-cultured lymphocytes of ovarian and renal carcinomas.

Authors:  E Halapi; Y Yamamoto; C Juhlin; M Jeddi-Tehrani; J Grunewald; R Andersson; C Hising; G Masucci; H Mellstedt; R Kiessling
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

8.  Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity.

Authors:  A Belldegrun; L M Muul; S A Rosenberg
Journal:  Cancer Res       Date:  1988-01-01       Impact factor: 12.701

9.  Dominant rearrangements among human tumor-infiltrating lymphocytes. Analysis of T-cells derived from 32 patients with melanoma, lung, and renal cell carcinoma.

Authors:  W T Bennett; F Pandolfi; B H Grove; G E Hawes; L A Boyle; R L Kradin; J T Kurnick
Journal:  Cancer       Date:  1992-05-01       Impact factor: 6.860

10.  Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brains of multiple sclerosis patients.

Authors:  J R Oksenberg; S Stuart; A B Begovich; R B Bell; H A Erlich; L Steinman; C C Bernard
Journal:  Nature       Date:  1990-05-24       Impact factor: 49.962

View more
  4 in total

1.  Comparison of T-cell receptor repertoire restriction in blood and tumor tissue of colorectal cancer patients.

Authors:  Sebastian Ochsenreither; Alberto Fusi; Susanne Wojtke; Antonia Busse; Natascha C Nüssler; Eckhard Thiel; Ulrich Keilholz; Dirk Nagorsen
Journal:  J Transl Med       Date:  2010-04-12       Impact factor: 5.531

2.  CD4+ T helper responses in squamous cell carcinoma of the head and neck.

Authors:  Kazuaki Chikamatsu; Koichi Sakakura; Takanori Yamamoto; Nobuhiko Furuya; Theresa L Whiteside; Keisuke Masuyama
Journal:  Oral Oncol       Date:  2008-01-24       Impact factor: 5.337

3.  Tumour-infiltrating lymphocytes mediate lysis of autologous squamous cell carcinomas of the head and neck.

Authors:  J Hald; N Rasmussen; M H Claesson
Journal:  Cancer Immunol Immunother       Date:  1995-10       Impact factor: 6.968

4.  Functional and T cell receptor gene usage analysis of cytotoxic T lymphocytes in fresh tumor-infiltrating lymphocytes from human head and neck cancer.

Authors:  K Chikamatsu; M Eura; K Nakano; K Masuyama; T Ishikawa
Journal:  Jpn J Cancer Res       Date:  1995-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.